Consolidated Index of Controlled Substances
L
3D rendering of LA-111
LA-111† 
UK: MDA Part I Class A Section 1(a) Lysergamide
US: CSA Schedule III Section c Subsection 9 Lysergic acid amide
⇒
PubChem: 442072; ChemSpider: 390611; Bluelight: LSA; Drugs Forum: LSA; Erowid: LSA; Wikipedia: Ergine
3D rendering of LAAM
LAAM
US: CSA Schedule II Section c Subsection 11 Levo-alphacetylmethadol
⇒
PubChem: 15130; ChemSpider: 14401; Wikipedia: Levomethadyl Acetate
3D rendering of Lacosamide
Lacosamide
US: CSA Schedule V Section e Subsection 2 Lacosamide
⇒
PubChem: 219078; ChemSpider: 189902; Bluelight: Lacosamide; Wikipedia: Lacosamide
3D rendering of LBJ
LBJ
CA: CDSA Schedule III Section 8 N-Methyl-3-piperidyl benzilate (LBJ)
US: CSA Schedule I Section d Subsection 28 N-Methyl-3-piperidyl benzilate
⇒
PubChem: 62495; ChemSpider: 56274; Wikipedia: N-Methyl-3-piperidyl benzilate
3D rendering of Lectopam
Lectopam® 
CA: CDSA Schedule IV Section 18 Subsection 2 Bromazepam
UK: MDA Part III Class C Section 1(a) Bromazepam
UN: Psychotropics Schedule IV Bromazepam
US: CSA Schedule IV Section c Subsection 4 Bromazepam
⇒
PubChem: 2441; ChemSpider: 2347; Drugs Forum: Bromazepam; Erowid: Bromazepam; Wikipedia: Bromazepam
3D rendering of Lefetamine
Lefetamine
CA: CDSA Schedule III Section 29 Lefetamine
UK: MDA Part II Class B Section 1(a) Lefetamine
UN: Psychotropics Schedule IV Lefetamine (SPA)
US: CSA Schedule IV Section f Subsection 12 SPA
⇒
PubChem: 22779; ChemSpider: 21356; Bluelight: Lefetamine; Drugs Forum: Lefetamine; Wikipedia: Lefetamine
3D rendering of Levallorphan
Levallorphan
CA: [not controlled] CDSA Schedule I Section 10 Subsection 12 Levallorphan
⇒
PubChem: 5359371; ChemSpider: 10481920; Wikipedia: Levallorphan
3D rendering of Levamfetamine
Levamfetamine
UN: Psychotropics Schedule II Levamfetamine (Levamphetamine)
⇒
PubChem: 32893; ChemSpider: 30477; Wikipedia: Amphetamine
3D rendering of Levamphetamine
Levamphetamine
UN: Psychotropics Schedule II Levamfetamine (Levamphetamine)
⇒
PubChem: 32893; ChemSpider: 30477; Wikipedia: Amphetamine
3D rendering of Levargorphan
Levargorphan
CA: [not controlled] CDSA Schedule I Section 10 Subsection 13 Levargorphan
⇒
PubChem: 6602241
3D rendering of Levo-alphacetylmethadol
Levo-alphacetylmethadol
US: CSA Schedule II Section c Subsection 11 Levo-alphacetylmethadol
⇒
PubChem: 15130; ChemSpider: 14401; Wikipedia: Levomethadyl Acetate
3D rendering of Levomethadyl acetate
Levomethadyl acetate
US: CSA Schedule II Section c Subsection 11 Levo-alphacetylmethadol
⇒
PubChem: 15130; ChemSpider: 14401; Wikipedia: Levomethadyl Acetate
3D rendering of Levomethamphetamine
Levomethamphetamine
UN: Psychotropics Schedule II Levomethamphetamine
⇒
PubChem: 36604; ChemSpider: 33634; Wikipedia: Levomethamphetamine
3D rendering of Levomethorphan
Levomethorphan
CA: CDSA Schedule I Section 10 Subsection 3 Levomethorphan
UK: MDA Part I Class A Section 1(a) Levomethorphan
UN: Narcotics Part 1 Section 1 Levomethorphan
US: CSA Schedule II Section c Subsection 12 Levomethorphan
⇒
PubChem: 5362449; ChemSpider: 4642423; Bluelight: Levomethorphan; Drugs Forum: Levomethorphan; Wikipedia: Levomethorphan
3D rendering of Levomoramide
Levomoramide
CA: CDSA Schedule I Section 9 Subsection 3 Levomoramide
UK: MDA Part I Class A Section 1(a) Levomoramide
UN: Narcotics Part 1 Section 1 Levomoramide
US: CSA Schedule I Section b Subsection 32 Levomoramide
⇒
PubChem: 10453145; ChemSpider: 8628561; Wikipedia: Levomoramide
3D rendering of Levonantradol
Levonantradol‡ 
UK: MDA Part II Class B Section 1(c) [9-Hydroxy-6-methyl-3-[5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl] acetate
⇒
Wikipedia: Levonantradol
3D rendering of Levophenacylmorphan
Levophenacylmorphan
CA: CDSA Schedule I Section 10 Subsection 5 Levophenacylmorphan
UK: MDA Part I Class A Section 1(a) Levophenacylmorphan
UN: Narcotics Part 1 Section 1 Levophenacylmorphan
US: CSA Schedule I Section b Subsection 33 Levophenacylmorphan
⇒
PubChem: 5362482; ChemSpider: 16736786; Wikipedia: Levophenacylmorphan
3D rendering of Levorphanol
Levorphanol
CA: CDSA Schedule I Section 10 Subsection 4 Levorphanol
UK: MDA Part I Class A Section 1(a) Levorphanol
UN: Narcotics Part 1 Section 1 Levorphanol
US: CSA Schedule II Section c Subsection 13 Levorphanol
⇒
PubChem: 5359272; ChemSpider: 16736212; Bluelight: Levorphanol ; Drugs Forum: Levorphanol ; Erowid: Levorphanol Synthesis; Wikipedia: Levorphanol
3D rendering of Librium
Librium® 
CA: CDSA Schedule IV Section 18 Subsection 4 Chlordiazepoxide
UK: MDA Part III Class C Section 1(a) Chlordiazepoxide
UN: Psychotropics Schedule IV Chlordiazepoxide
US: CSA Schedule IV Section c Subsection 9 Chlordiazepoxide
⇒
PubChem: 2712; ChemSpider: 10248513; Drugs Forum: Chlordiazepoxide; Erowid: Chlordiazepoxide; Wikipedia: Chlordiazepoxide
3D rendering of Lisdexamfetamine
Lisdexamfetamine
UK: MDA Part II Class B Section 1(a) Lisdexamfetamine
US: CSA Schedule II Section d Subsection 5 Lisdexamfetamine
⇒
PubChem: 11597698; ChemSpider: 9772458; Wikipedia: Lisdexamfetamine
3D rendering of Lofentanil
Lofentanil
UK: MDA Part I Class A Section 1(a) Lofentanil
⇒
PubChem: 123642 65499; ChemSpider: 110226; Wikipedia: Lofentanil
Lophophora
CA: [not controlled] CDSA Schedule III Section 17 Lophophora
US: CSA Schedule I Section d Subsection 26 Peyote
⇒
PubChem: 135309929 135330128; Bluelight: Peyote; Drugs Forum: Peyote; Erowid: Peyote; Wikipedia: Peyote
Lophophora williamsii† 
CA: [not controlled] CDSA Schedule III Section 17 Lophophora
US: CSA Schedule I Section d Subsection 26 Peyote
⇒
PubChem: 135309929 135330128; Bluelight: Peyote; Drugs Forum: Peyote; Erowid: Peyote; Wikipedia: Peyote
3D rendering of Loprazolam
Loprazolam
CA: CDSA Schedule IV Section 18 Subsection 19 Loprazolam
UK: MDA Part III Class C Section 1(a) Loprazolam
UN: Psychotropics Schedule IV Loprazolam
US: CSA Schedule IV Section c Subsection 29 Loprazolam
⇒
PubChem: 3033860; ChemSpider: 2298440; Wikipedia: Loprazolam
3D rendering of Lorazepam
Lorazepam
CA: CDSA Schedule IV Section 18 Subsection 20 Lorazepam
UK: MDA Part III Class C Section 1(a) Lorazepam
UN: Psychotropics Schedule IV Lorazepam
US: CSA Schedule IV Section c Subsection 30 Lorazepam
⇒
PubChem: 3958; ChemSpider: 3821; Bluelight: Lorazepam; Drugs Forum: Lorazepam; Erowid: Lorazepam; Wikipedia: Lorazepam
3D rendering of Lorcaserin
Lorcaserin
US: CSA Schedule IV Section e Subsection 1 Lorcaserin
⇒
PubChem: 11658860; ChemSpider: 9833595; Bluelight: Lorcaserin; Erowid: Lorcaserin; Wikipedia: Lorcaserin
3D rendering of Lormetazepam
Lormetazepam
CA: CDSA Schedule IV Section 18 Subsection 21 Lormetazepam
UK: MDA Part III Class C Section 1(a) Lormetazepam
UN: Psychotropics Schedule IV Lormetazepam
US: CSA Schedule IV Section c Subsection 31 Lormetazepam
⇒
PubChem: 13314; ChemSpider: 12750; Drugs Forum: Lormetazepam; Wikipedia: Lormetazepam
3D rendering of LSA
LSA† 
UK: MDA Part I Class A Section 1(a) Lysergamide
US: CSA Schedule III Section c Subsection 9 Lysergic acid amide
⇒
PubChem: 442072; ChemSpider: 390611; Bluelight: LSA; Drugs Forum: LSA; Erowid: LSA; Wikipedia: Ergine
3D rendering of LSD
LSD
CA: CDSA Schedule III Section 5 Lysergic acid diethylamide
UK: MDA Part I Class A Section 1(a) Lysergide
UN: Psychotropics Schedule I (+)-Lysergide (LSD) (LSD-25)
US: CSA Schedule I Section d Subsection 22 Lysergic acid diethylamide
⇒
PubChem: 5761; ChemSpider: 5558; Bluelight: LSD; Drugs Forum: LSD; Erowid: LSD; TiHKAL • info: LSD; Wikipedia: Lysergic acid diethylamide
3D rendering of LSD-25
LSD-25
CA: CDSA Schedule III Section 5 Lysergic acid diethylamide
UK: MDA Part I Class A Section 1(a) Lysergide
UN: Psychotropics Schedule I (+)-Lysergide (LSD) (LSD-25)
US: CSA Schedule I Section d Subsection 22 Lysergic acid diethylamide
⇒
PubChem: 5761; ChemSpider: 5558; Bluelight: LSD; Drugs Forum: LSD; Erowid: LSD; TiHKAL • info: LSD; Wikipedia: Lysergic acid diethylamide
3D rendering of LSZ
LSZ
UK: MDA Part I Class A Section 1(a) 2,4-Dimethylazetidinyl{(6aR,9R)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinolin-9-yl}methanone
3D rendering of Lysergamide
Lysergamide
UK: MDA Part I Class A Section 1(a) Lysergamide
US: CSA Schedule III Section c Subsection 9 Lysergic acid amide
⇒
PubChem: 442072; ChemSpider: 390611; Bluelight: LSA; Drugs Forum: LSA; Erowid: LSA; Wikipedia: Ergine
3D rendering of Lysergic acid
Lysergic acid
CA: CDSA Schedule VI Part 1 Subsection 8 Lysergic acid
EU: Drug precursors Annex I Category 1 Lysergic acid
UK: MDA Drug precursors Annex I Category 1 Lysergic acid
UN: Precursors Table I Lysergic acid
US: CSA Schedule III Section c Subsection 8 Lysergic acid
⇒
PubChem: 6717; ChemSpider: 6461; Wikipedia: Lysergic acid
3D rendering of Lysergic acid amide
Lysergic acid amide
UK: MDA Part I Class A Section 1(a) Lysergamide
US: CSA Schedule III Section c Subsection 9 Lysergic acid amide
⇒
PubChem: 442072; ChemSpider: 390611; Bluelight: LSA; Drugs Forum: LSA; Erowid: LSA; Wikipedia: Ergine
3D rendering of Lysergic acid diethylamide
Lysergic acid diethylamide
CA: CDSA Schedule III Section 5 Lysergic acid diethylamide
UK: MDA Part I Class A Section 1(a) Lysergide
UN: Psychotropics Schedule I (+)-Lysergide (LSD) (LSD-25)
US: CSA Schedule I Section d Subsection 22 Lysergic acid diethylamide
⇒
PubChem: 5761; ChemSpider: 5558; Bluelight: LSD; Drugs Forum: LSD; Erowid: LSD; TiHKAL • info: LSD; Wikipedia: Lysergic acid diethylamide
3D rendering of Lysergide
Lysergide
CA: CDSA Schedule III Section 5 Lysergic acid diethylamide
UK: MDA Part I Class A Section 1(a) Lysergide
UN: Psychotropics Schedule I (+)-Lysergide (LSD) (LSD-25)
US: CSA Schedule I Section d Subsection 22 Lysergic acid diethylamide
⇒
PubChem: 5761; ChemSpider: 5558; Bluelight: LSD; Drugs Forum: LSD; Erowid: LSD; TiHKAL • info: LSD; Wikipedia: Lysergic acid diethylamide
3D rendering of (+)-Lysergide
(+)-Lysergide
CA: CDSA Schedule III Section 5 Lysergic acid diethylamide
UK: MDA Part I Class A Section 1(a) Lysergide
UN: Psychotropics Schedule I (+)-Lysergide (LSD) (LSD-25)
US: CSA Schedule I Section d Subsection 22 Lysergic acid diethylamide
⇒
PubChem: 5761; ChemSpider: 5558; Bluelight: LSD; Drugs Forum: LSD; Erowid: LSD; TiHKAL • info: LSD; Wikipedia: Lysergic acid diethylamide
11 March 2016 · Creative Commons BY-NC-SA ·